PhaseBio Pharmaceuticals, Inc. (PHAS)

Financing Cash Flow

$5.17M

TTM · Period ending: · USD

PHAS logo

PHAS Financing Cash Flow

Latest reported$5.17M
PHAS TTM Cash from Financing ($13.56M → $5.17M)
High-resolution chart · PNG

PHAS financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

PhaseBio Pharmaceuticals, Inc. Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
5,170,000
4,420,000
63,773,000
56,849,000
60,511,000
64,739,000
15,466,000
20,176,000
17,907,000
63,751,000
53,528,000
92,265,000
111,387,000
64,475,000
64,797,000
32,746,000
13,560,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.